Drugs / SUZ
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06834009 | Mar → Apr 2025 | — | Vertex Pharmaceuticals Incorporated | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SUZ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06834009 ↗ |
| Route | Oral | “Powder for oral administration.” NCT06834009 ↗ |